Chemical Compound

Telaprevir

CAS Registry Number 402957-28-2
Back to search Request a Quote
Telaprevir chemical structure
Primary Record

Telaprevir

In stock
5,082 g
Purity
99.5 %
CAS
402957-28-2

Compound Identifiers & Properties

CAS
402957-28-2
PubChem CID
3010818
SMILES
CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5
Canonical SMILES
CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1

Names & Synonyms

  • Telaprevir
  • Incivek
  • Incivo
  • 402957-28-2
  • Telavic
  • VX-950
  • Telaprevir (VX-950)
  • S-Telaprevir
  • telaprevirum
  • Telaprevir-d4
  • MP-424
  • Incivek(TM)
  • VX 950
  • VX950 cpd
  • Incivek (TN)
  • Telaprevir/VX950
  • Incivo (TN)
  • 2-Chlorocinnamic acid
  • Telaprevir,VX-950
  • Telaprevir [USAN:INN]
  • Telaprevir (VX950)
  • Telaprevir(VX-950)
  • Telaprevir; VX-950
  • VX-950(Telaprevir)
  • RefChem:56918
  • TELAPREVIR [MI]
  • AC1MHSY4
  • TELAPREVIR [INN]
  • TELAPREVIR [JAN]
  • TELAPREVIR [USAN]
  • VX-950 (Telaprevir)
  • LY-570310
  • MP 424
  • TELAPREVIR [VANDF]
  • cc-71
  • CHEBI:68595
  • D07ZAH
  • D0X9CH
  • Epitope ID:231712
  • Telaprevir (VX-950)?
  • UNII-655M5O3W0U
  • TELAPREVIR [MART.]
  • CHEMBL231813
  • VRT 111950
  • VRT-111950
  • 655M5O3W0U
  • TELAPREVIR [WHO-DD]
  • MFCD11616089
  • HSDB 8125
  • SCHEMBL183996
  • Telaprevir (JAN/USAN/INN)
  • DTXSID40193304
  • C36H53N7O6
  • GTPL7871
  • LY 570310
  • orb1300995
  • SCHEMBL29358151
  • TELAPREVIR [ORANGE BOOK]
  • DTXCID10115795
  • EX-A006
  • J05AP02
  • BBAWEDCPNXPBQM-GDEBMMAJSA-N
  • AIDS213006
  • GLXC-90215
  • VX950
  • ACH-1625
  • AIDS-213006
  • AOB87136
  • Telaprevir pound VX-950 pound(c)
  • ZINC3992480
  • ABP000273
  • BDBM50326056
  • EBC-27428
  • FD7166
  • s1538
  • VRT111950
  • AKOS005145815
  • ACN-046786
  • AN-3508
  • CCG-270366
  • CID3010818
  • CS-0285
  • CS-O-02532
  • DB05521
  • FT32861
  • CID:3010818
  • NCGC00346545-03
  • AS-16995
  • HY-10235
  • SC-28369
  • SY017945
  • SID:134223970
  • (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide
  • AB0027979
  • ST1151107
  • A4031
  • W9903
  • J2.052.474J
  • WO-00218369
  • A18739
  • D09012
  • Q-4436
  • 957T282
  • C486464
  • EN300-26212550
  • Q408557
  • (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide
  • BRD-K72912098-001-02-3
  • Z2235802141
  • (1S,3aR,6aS)-(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-6-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethyl-butanoyl]-N-[(1S)-1-[2-(cyclopropylamino)-2-oxo-acetyl]butyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide
  • Cyclopenta(c)pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydro-, (1S,3aR,6aS)-
  • TVR
  • (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-1-carboxamide
  • (3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-[(pyrazin-2-yl)formamido]acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide
  • Telaprevir, 98%, Hepatitis c virus (HCV)NS3-4Aserine protease inhibitors - 10MG 10mg
  • (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-((2S)-2-(((2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl)amino)-3,3-dimethylbutanoyl)-N-((3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta(c)pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxo-hexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cydopropylamino)-1,2-dioxo-hexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-3-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-Cyclohexyl[(pyrazinylcarbonyl)amino]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[(cyclopropylamino)oxoacetyl]butyl] octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-2-{N-[(2S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetyl]-3-methyl-L-valyl}-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (1S,3aR,6aS)-N-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide
  • (3S)-3-(((1S,3aR,6aS)-2-((2S)-2-((2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido)-3,3-dimethylbutanoyl)-octahydrocyclopenta(c)pyrrol-1-yl)formamido)-N-cyclopropyl-2-oxohexanamide
  • (3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide
  • (3S,3aS,6aR)-2-((2S)-2-(((2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl)amino)-3,3-dimethylbutanoyl)-N-((3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta(c)pyrrole-3-carboxamide
  • 1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1S)-1-[2-[(cyclopropyl-d4)amino]-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide; LY 570310-d4; MP 424-d4; VRT 111950-d4; VX 950-d4;
  • 2-(2-{2-Cyclohexyl-2-[(pyrazine-2-carbonyl)-amino]-acetylamino}-3,3-dimethyl-butyryl)-octahydro-cyclopenta[c]pyrrole-1-carboxylic acid (1-cyclopropylaminooxalyl-butyl)-amide
  • 304853-42-7
  • 569364-34-7
  • Cyclopenta[c]pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydro-, (1S,3aR,6aS)-; Cyclopenta[c]pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1S)-1-[(cyclopropylamino)oxoacetyl]butyl]octahydro-, (1S,3aR,6aS)- (9CI); Incivek; Incivo; LY 570310; MP 424; S-Telaprevir; Telaprevir; Telavic; VRT 111950; VX 950